In a rapidly expanding health supplement market facing challenges such as counterfeit products, low-quality goods, and unclear origins, Aikya Pharmaceutical Joint Stock Company remains steadfast in its commitment to sustainable development. We uphold product quality as our highest pledge and community health as our consistent, long-term mission.
Driven by a passion to serve Vietnamese health from the very beginning
Founded in 2016, Aikya is a 100% Vietnamese-owned enterprise. More than just a pharmaceutical company, Aikya positions itself as a comprehensive healthcare solutions provider—spanning research, development, manufacturing, and distribution.
Guided by a spirit of service, Aikya has remained true to its vision from day one: understanding Vietnamese people and serving them wholeheartedly. That’s why we consistently invest in expert personnel, advanced technologies, and robust quality control systems. We stay ahead of industry trends and apply pharmaceutical innovations to develop products that meet the physical needs and preferences of the Vietnamese population.
Currently, Aikya’s healthcare ecosystem offers over 600 products across pharmaceuticals, health supplements, cosmetics, and medical devices. These products are developed by our three member companies — TV.PHARM, MEBIPHAR, and S.PHARM — collectively serving the diverse needs of community healthcare in Vietnam.
State-of-the-Art Manufacturing – A Guarantee of Quality and Trust
One of the core foundations of Aikya’s reputation lies in its modern manufacturing system, which strictly adheres to pharmaceutical production standards. A prime example is TV.PHARM — Aikya’s flagship manufacturing unit — located in Tra Vinh, spanning 30,000 square meters and operating in full compliance with WHO-GMP, GLP, GSP, and GDP standards.
Standardized Investment in Manufacturing – Strengthening Competitiveness, Upholding Public Health
Aikya’s strategic investment in standardized manufacturing facilities not only enhances its competitive edge but also reflects a long-term commitment to delivering safe, effective products to the Vietnamese people. In a market still facing quality fluctuations, the presence of rigorously certified plants like TV.PHARM serves as a testament to our technical excellence — and more importantly, a concrete step in safeguarding public health at its root.
With over 30 years of development, TV.PHARM boasts robust production capacity and strict quality control processes. Its team of pharmacists and technicians undergo regular, professional training to ensure that every product meets high standards of quality, consistency, and stability across all production batches.
Currently, Aikya is developing a High-Tech Pharmaceutical Industrial Cluster in Tra Vinh, with a total investment of over VND 650 billion. This strategic project is designed to meet international standards such as GMP-EU, FDA, and PIC/S — marking a significant step forward in elevating Vietnam’s pharmaceutical industry on the global stage.
Driven by Real Needs – Committed to Continuous Innovation
Aikya’s product portfolio spans a wide range of therapeutic areas, including antibiotics, pain relief and antipyretics, digestive health, respiratory care, musculoskeletal support, cerebral circulation, cardiovascular and diabetes management, nutrition, and skincare. Each product line is developed based on the real needs of patients and physicians, with a strong emphasis on scientific rigor and practical application.
Some of our standout products have become familiar names among Vietnamese consumers, such as:
Travicol, Orenko, Suspengel, Fexophar, Metformin, Melomax, Phariton Active, Phariton Ginseng, Phariton Detox, EUCA Syrup, Calcitra DK2, Vitamin A-D, E400-TVP, and more.
Alongside our commitment to quality, Aikya continually works to optimize costs, ensuring broader accessibility — especially for people in rural areas, where healthcare resources remain limited and the need for affordable, effective solutions is high.
Spreading Sustainable Value Within Vietnam’s Healthcare Ecosystem
Aikya’s products are widely available across major pharmacy chains such as Pharmacity and Long Châu, and are present in numerous central and provincial hospitals including Cho Ray, Gia Dinh, Hoa Hao, and 115 Hospital. This widespread presence reflects the strong trust placed in Aikya’s product quality by both healthcare professionals and Vietnamese consumers — a testament to the value of a homegrown pharmaceutical brand.
At Aikya, growth is not solely measured by business success. We are deeply committed to creating meaningful social impact through practical community initiatives: organizing health education campaigns, supporting free medical check-ups, and assisting grassroots doctors and pharmacists — especially in underserved areas.
Aikya also actively participates in various social welfare programs, including “Lighting the Sea for Fishermen”, contributions to funds for the poor, education support, aid for Agent Orange victims, building rural concrete bridges and charity houses, caring for Vietnamese Heroic Mothers, and providing relief to communities affected by natural disasters and floods.
For Aikya, public health is not just a destination — it is a long-term journey that requires compassion, perseverance, and shared responsibility. And this journey continues, with every product we bring to life standing as both a professional achievement and a lasting testament to our unwavering commitment to serving the Vietnamese people with the very best we have to offer.
